Related Experiment Video
Updated: Aug 31, 2025

06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
2.4K
MicroRNA and Their Potential Role in Conjunctival Disorders
Nazmul Huda Syed1, Embong Zunaina1, Shahidan Wan-Nazatul Shima2
1Department of Ophthalmology and Visual Science, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
Korean Journal of Ophthalmology : KJO
|August 21, 2022
Summary
MicroRNAs (miRNAs) are key regulators in conjunctival diseases, influencing processes like inflammation and cell growth. Further research is needed to confirm their potential as diagnostic and therapeutic biomarkers for these eye conditions.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small noncoding RNA molecules regulating gene expression post-transcriptionally.
- miRNAs are crucial in cellular processes including inflammation, differentiation, proliferation, and apoptosis, relevant to ocular diseases.
- Conjunctival diseases are increasingly investigated for miRNA involvement due to easier accessibility.
Purpose of the Study:
- To review and understand the role of miRNAs in various conjunctival diseases.
- To highlight miRNAs as mediators in conjunctival pathological conditions.
- To explore the diagnostic and therapeutic potential of miRNAs in ophthalmology.
Main Methods:
- A narrative review of literature was conducted.
- Searches were performed in PubMed, Scopus, and Web of Science databases.
- Included original articles from the last 10 years, using human and animal models.
Main Results:
- 27 studies met the inclusion criteria, indicating a strong correlation between miRNAs and conjunctival pathologies.
- miRNAs regulate key physiological processes like cell differentiation, proliferation, apoptosis, development, and inflammation.
- Pterygium showed the most miRNA research, while allergic conjunctivitis research is nascent.
Conclusions:
- miRNAs play significant roles in various conjunctival diseases by regulating signaling pathways and genes.
- miRNAs show promise as noninvasive biomarkers for diagnosis, prognosis, and therapy in conjunctival pathologies.
- Extensive studies are required to validate miRNAs as reliable biomarkers and for targeted therapy in conjunctival diseases.

